Evidence map›Paper›PMID 30866416›Full record

ReviewMaterials (Basel, Switzerland)2019

Nanomaterial Applications in Photothermal Therapy for Cancer.

Austin C V Doughty, Ashley R Hoover, Elivia Layton, Cynthia K Murray, Eric W Howard, Wei R Chen

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Comparison of structural, optical, and thermal properties in MoSJournal of materials science. Materials in medicine · 2025
    Article
  12. Article
  13. Review
  14. Emerging nanoplatforms towards microenvironment-responsive glioma therapy.Medical oncology (Northwood, London, England) · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Improvement photothermal property of MoSJournal of materials science. Materials in medicine · 2024
    Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Austin C V DoughtyBiophotonics Research Laboratory, Center for Interdisciplinary Biomedical Education and Research, College of Mathematics and Science, University of Central Oklahoma, Edmond, OH 73034, USA. adoughty1@uco.edu.
Ashley R HooverBiophotonics Research Laboratory, Center for Interdisciplinary Biomedical Education and Research, College of Mathematics and Science, University of Central Oklahoma, Edmond, OH 73034, USA. ahoover7@uco.edu.
Elivia LaytonBiophotonics Research Laboratory, Center for Interdisciplinary Biomedical Education and Research, College of Mathematics and Science, University of Central Oklahoma, Edmond, OH 73034, USA. elayton3@uco.edu.
Cynthia K MurrayDepartment of Mathematics and Statistics, College of Mathematics and Science, University of Central Oklahoma, Edmond, OH 73034, USA. cmurray@uco.edu.
Eric W HowardDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OH 73104, USA. Eric-Howard@ouhsc.edu.
Wei R ChenBiophotonics Research Laboratory, Center for Interdisciplinary Biomedical Education and Research, College of Mathematics and Science, University of Central Oklahoma, Edmond, OH 73034, USA. wchen@uco.edu.

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Mark L Lang · 2012 to 2026
$60.2M
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancersR01CA205348 · NCI · UNIVERSITY OF OKLAHOMA · PI CHEN, WEI R. · 2017 to 2021
$1.5M
A Novel Multifunctional Bionanoprobe-Based Phototherapy for Metastatic CancersR21EB015509 · NIBIB · UNIVERSITY OF CENTRAL OKLAHOMA · PI CHEN, WEI R. · 2013 to 2014
$350k
NCI NIH HHS R01 CA205348NIBIB NIH HHS R21 EB015509NIGMS NIH HHS P20 GM103447NIH HHS R01 CA205348NIH HHS R21 EB015509NIH HHS RS20132225-106Oklahoma Center for the Advancement of Science and Technology HR16-085
6 · The paper itself

Abstract

As a result of their unique compositions and properties, nanomaterials have recently seen a tremendous increase in use for novel cancer therapies. By taking advantage of the optical absorption of near-infrared light, researchers have utilized nanostructures such as carbon nanotubes, gold nanorods, and graphene oxide sheets to enhance photothermal therapies and target the effect on the tumor tissue. However, new uses for nanomaterials in targeted cancer therapy are coming to light, and the efficacy of photothermal therapy has increased dramatically. In this work, we review some of the current applications of nanomaterials to enhance photothermal therapy, specifically as photothermal absorbers, drug delivery vehicles, photoimmunological agents, and theranostic tools.

Indexed as

ablationcancercombination therapymetastaticnanomaterialsphotothermal therapy

Identifiers

PMID30866416
PMCPMC6427777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.